Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686101 · ClinicalTrials.gov registry record
Knowledge and Perception of Smoking Risks/Consequences
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 200
- Enrollment target
NCT00686101: Completed study, sponsored by University of Maryland, Baltimore.
NCT00686101 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00686101 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This proposed 2-year questionnaire study examines views and attitudes regarding health risks of cigarette smoking, smoking patterns and motivators for cessation in smokers who suffer from schizophrenia compared to a sample of smokers without a major psychotic disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-06 |
What the finished NCT00686101 record still lists
NCT00686101 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00686101 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00686101 about?
NCT00686101 is a clinical study titled "Knowledge and Perception of Smoking Risks/Consequences". This proposed 2-year questionnaire study examines views and attitudes regarding health risks of cigarette smoking, smoking patterns and motivators for cessation in smokers who suffer from schizophrenia compared to a sample of smokers without a major psychotic disorder.
What is the current status of trial NCT00686101?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2007-12. Estimated completion is 2009-06.
Who is sponsoring clinical trial NCT00686101?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia